Novartis invests in digital trials

Novartis has expanded an alliance with Science 37 Inc of the US to launch up to 10 clinical trials over the next three years that will be conducted at a participant’s home or a physician’s officer rather than at a formal clinical trial site. Science 37 is a mobile technology and clinical trial company.

Full text available to subscribers only. Click here for information on subscribing to MedNous.